OAKLAND, Calif., Oct. 19, 2015 (SEND2PRESS NEWSWIRE) — Council for Vaccine Safety, and A Voice for Choice, in collaboration with community leaders, announce that on October 24, 2015 at 12 noon, protesters will rally at Frank Ogawa Plaza in Oakland, Calif. in solidarity with the Truth, Transparency and Freedom Rally happening on the same day […]
Archive | Pharma
RxQ Antioxidant Complex for Those Faced with Excessive Oxidative Stressors from Busy and Stressful Lifestyle
SAN PEDRO, Calif., July 17, 2015 (SEND2PRESS NEWSWIRE) — Schoenwetter Supplements, LLC is excited to announce the release of an advanced concept formulation of antioxidants, RxQ Antioxidant Complex. Its proprietary antioxidant formula takes into consideration not only adding antioxidants that can rapidly be depleted but is mindful of the necessary other constituents that serve to […]
Release and Book Signing of BioTE Medical President Gary Donovitz M.D. ‘Age Healthier Live Happier’ at Age Management Medicine Group (AMMG) Conference
ORLANDO, Fla., April 23, 2015 (SEND2PRESS NEWSWIRE) — BioTE Medical President and Founder Gary Donovitz M.D. releases his book ‘Age Healthier Live Happier – Avoiding Over-Medication through Natural Hormone Balance’ (ISBN: 9780990706458) to kick off the Age Management Medicine Group Conference at JW Marriott / Ritz Carlton Grande Lakes April 23 – 26, 2015.
Weitz & Luxenberg’s Relkin Appointed to Xarelto MDL Leadership Team
NEW YORK, N.Y., Feb. 11, 2015 (SEND2PRESS NEWSWIRE) — Ellen Relkin, of counsel attorney with Weitz and Luxenberg, P.C., has been named to the plaintiffs’ steering committee created by judicial order to facilitate lawsuits against the makers of the anticoagulant drug Xarelto, the personal injury and mass tort law firm today announced.
Paragon BioTeck Receives CE Mark Approval on Comfortear Lacrisolve Absorbable Punctum Plug
PORTLAND, Ore., Nov. 17, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug. CE mark approval is recognized and associated […]
Paragon BioTeck to Exhibit at American Academy of Ophthalmology Annual Meeting in Chicago
PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 – 21.
Novel Protein May Hold Promise for Enhancing Artificial Tear Formulations
PLYMOUTH, Minn., Oct. 14, 2014 (SEND2PRESS NEWSWIRE) — SilkTears, LLC, a privately held, research-based and product-driven biotechnology company, announced today that advances in protein-based excipient technology may allow for the development of artificial tear products that will more closely represent certain characteristics of the natural makeup of the tear film, and may help the significant […]
Lakewood College announces program to allow students to graduate from the Pharmacy Technician Certificate Program debt-free
CLEVELAND, Ohio, July 1, 2014 (SEND2PRESS NEWSWIRE) — Lakewood College is pleased to announce a new payment plan option that will allow students to graduate from the Pharmacy Technician Certificate Program without going thousands of dollars into debt.
Paragon BioTeck announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available
PORTLAND, Ore., June 4, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler.
Weitz and Luxenberg – Jury Awards $9 Billion to Diabetic Put at Cancer Risk by Actos
NEW YORK CITY, N.Y., April 9, 2014 (SEND2PRESS NEWSWIRE) — A Louisiana jury has awarded $9 billion to a New York man who developed bladder cancer after taking Actos, Weitz and Luxenberg announced today. The verdict, issued Monday night, orders Takeda Pharmaceuticals to pay $6 billion in punitive damages, and Eli Lilly to pay $3 […]